Bicalutamide Market by Deployment, by Applications, by Type, by End-User & by Technology 2032
Bicalutamide Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030.
Between 2018 and 2022, the Bicalutamide market showed steady growth, fueled by rising prostate cancer incidences and the increasing aging population worldwide. Bicalutamide's role in treating both localized and advanced prostate cancer helped boost demand. During this period, the market was also supported by the increasing availability of generics, which contributed to reduced treatment costs, broadening access. Additionally, the growing awareness of prostate cancer and advances in diagnostic technologies pushed for more tailored treatment regimens, further boosting the medication's popularity.
In terms of market dynamics, the period from 2018 to 2022 also saw the introduction of newer drugs like enzalutamide and abiraterone, which presented competition to Bicalutamide. However, Bicalutamide maintained a strong position due to its established effectiveness, fewer side effects, and cost-effectiveness compared to newer, more expensive treatments. Regulatory approvals for generic versions in multiple regions also helped sustain its market presence.
The outlook for the Bicalutamide market from 2023 to 2033 is anticipated to evolve with new trends and emerging factors. With an increasing focus on precision medicine and targeted therapies, the demand for Bicalutamide may be impacted by innovative treatments that are being developed to address prostate cancer more effectively and with fewer side effects. However, the aging global population and the growing number of prostate cancer cases will continue to sustain demand for Bicalutamide, as it remains a critical treatment option for many patients, especially in regions with limited access to newer, more costly medications.
The rise of personalized medicine and the growing role of biotechnology in oncology are also expected to influence the future trajectory of the Bicalutamide market. Furthermore, emerging markets in Asia and Latin America are projected to contribute significantly to demand, given the increasing healthcare access and rising awareness about prostate cancer in these regions. As such, while the market may face challenges from novel treatments, the steady need for Bicalutamide in both established and emerging markets suggests a continued, though evolving, demand in the coming decades.
Get an In-Depth Research Analysis of the Global Bicalutamide Market Size And Forecast [2025-2032]
The Bicalutamide market has experienced significant shifts between 2018 and 2022, driven by an increasing demand for effective prostate cancer treatments. As a non-steroidal anti-androgen medication, Bicalutamide has been widely used for managing prostate cancer by inhibiting androgen receptor activity. This article examines the market trends during 2018 to 2022 and compares them with the expected demand from 2023 to 2033, shedding light on how evolving healthcare dynamics, regulatory approvals, and treatment practices influence the market's trajectory.
Who are the largest Global manufacturers in the Bicalutamide industry?
- AstraZeneca
- CORDEN PHARMA GMBH
- Zeneca GmbH
- Actavis Pharma
- Sivem Pharmaceuticals
- Sorres Pharma
- Fresenius Kabi
- ANI Pharmaceuticals
- Accel Pharma
- Apotex Corporation
- AstraZeneca
- Shanghai Zhaohui Pharmaceutical
- Zhejiang Haizheng Pharmaceutical
- Shanxi Zhendong Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Bicalutamide Market Size And Forecast [2025-2032]
What are the factors driving the growth of the Global Bicalutamide Market?
Growing demand for below applications around the world has had a direct impact on the growth of the Global Bicalutamide Market
- Single Drug For Prostate Cancer
- Combined Chemotherapy For Prostate Cancer
- Combined Radiation Therapy Or Castration For Prostate Cancer
What are the types of Bicalutamide available in the Market?
Based on Types the Market is categorized into Below types that held the largest Bicalutamide market share In 2023.
- Tablets
- Capsule
Which regions are leading the Global Bicalutamide Market?
- Global (United States, Global and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil, Argentina, Columbia, etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Bicalutamide Market Research Analysis
Detailed TOC of Global Bicalutamide Market Research Report, 2024-2032
1. Introduction of the Global Bicalutamide Market
- Overview of the Market
- Scope of Report
- Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
- Data Mining
- Validation
- Primary Interviews
- List of Data Sources
4. Global Bicalutamide Market Outlook
- Overview
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porters Five Force Model
- Value Chain Analysis
5. Global Bicalutamide Market, By Type
6. Global Bicalutamide Market, By Application
7. Global Bicalutamide Market, By Geography
- Global
- Europe
- Asia Pacific
- Rest of the World
8. Global Bicalutamide Market Competitive Landscape
- Overview
- Company Market Ranking
- Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768